New Age Alpha Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8K Sell
94
-16
-15% -$4.43K ﹤0.01% 913
2026
Q1
$32.5K Buy
110
+32
+41% +$9.51K ﹤0.01% 734
2025
Q4
$21.3K Sell
78
-731
-90% -$199K ﹤0.01% 729
2025
Q3
$219K Buy
809
+671
+486% +$183K 0.01% 620
2025
Q2
$38K Hold
138
﹤0.01% 784
2025
Q1
$36.6K Buy
138
+9
+7% +$2.22K ﹤0.01% 837
2024
Q4
$30K Buy
129
+43
+50% +$9.89K ﹤0.01% 829
2024
Q3
$19K Buy
+86
New +$17.8K 0.01% 85

Other funds holding CME

New Age Alpha Advisors's CME Position: Q2 2026 in Review

New Age Alpha Advisors reduced its CME Group (CME) stake by 15% in Q2 2026, selling an estimated $4.43K and leaving 94 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

New Age Alpha Advisors first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $219K in Q3 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • New Age Alpha Advisors held 94 shares of CME Group worth $20.8K as of Q2 2026.
  • New Age Alpha Advisors sold 16 CME Group shares in Q2 2026, an estimated $4.43K.
  • CME Group made up ﹤0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #913 holding.
  • New Age Alpha Advisors first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • New Age Alpha Advisors's CME Group position peaked at $219K in Q3 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.